What we measured. Told plainly.
Before we say anything about how a formula performs, real people use it first — across different climates and different skin conditions. What follows is exactly what kind of evidence that is, and what kind it isn't.
31 testers. Three climates. One formula.
Every remaïa formula goes through a structured testing phase before it's finalized. Testers are spread across genuinely different climate conditions, because skin behaves differently in each — and a formula that only works in one climate isn't finished yet.
Tester profiles are intentionally varied — including women navigating perimenopausal skin changes, and testers whose professions expose their skin to unusually harsh conditions, such as repeated cabin-altitude dryness.
Quantified results from the testing round — the actual percentages — are being finalized and will be added here once confirmed. We'd rather leave this space honestly incomplete than publish a placeholder number.
Self-assessment. Not a clinical trial.
What testers report is real — but it's self-reported experience over time, gathered outside a controlled clinical setting. We don't call it clinical evidence, and we don't let the language imply more rigor than it has.
Concretely: when a tester tells us their skin felt less tight after a week, that's a genuine, individually meaningful data point. It is not the same category of evidence as a dermatologist-supervised clinical study with an untreated control group, and we won't blur the two just because the distinction is inconvenient.
Regulators, scientists, and — frankly — anyone who's been burned by a skincare promise before all read "clinically proven" as a specific, verifiable claim. We'd rather be trusted for what we can actually stand behind than borrow language we haven't earned.